Antifungal Drug-Drug Interactions with Commonly Used Pharmaceutics in European Pediatric Patients with Acute Lymphoblastic Leukemia.
acute lymphoblastic leukemia
antifungal agents
children
drug interactions
liposomal amphotericin B
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
12 Jul 2023
12 Jul 2023
Historique:
received:
17
05
2023
revised:
26
06
2023
accepted:
06
07
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
Leukemia is one of the leading childhood malignancies, with acute lymphoblastic leukemia (ALL) being the most common type. Invasive fungal disease is a concerning problem also at pediatric hemato-oncology units. Available guidelines underline the need for antifungal prophylaxis and give recommendations for proper treatment in various clinical scenarios. Nonetheless, antifungal agents are often involved in drug-drug interaction (DDI) occurrence. The prediction of those interactions in the pediatric population is complicated because of the physiological differences in adults, and the lack of pharmacological data. In this review, we discuss the potential DDIs between antifungal agents and commonly used pharmaceutics in pediatric hemato-oncology settings, with special emphasis on the use of liposomal amphotericin B and ALL treatment. We obtained information from Micromedex
Identifiants
pubmed: 37510753
pii: jcm12144637
doi: 10.3390/jcm12144637
pmc: PMC10380616
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
J Oncol Pharm Pract. 2017 Sep;23(6):443-453
pubmed: 27511216
Br J Clin Pharmacol. 2019 Mar;85(3):590-600
pubmed: 30536405
Pediatr Blood Cancer. 2017 Jul;64(7):
pubmed: 28205376
Cancer. 2008 Jan 15;112(2):416-32
pubmed: 18074355
Clin Pharmacol Ther. 2003 Dec;74(6):543-54
pubmed: 14663457
Expert Opin Drug Saf. 2012 Jan;11(1):95-105
pubmed: 21548838
Infect Dis Clin North Am. 2016 Mar;30(1):51-83
pubmed: 26739608
Ther Adv Drug Saf. 2022 Dec 16;13:20420986221143266
pubmed: 36545565
Cancer Res Treat. 2016 Jul;48(3):869-82
pubmed: 26790965
Arch Toxicol. 2017 Apr;91(4):1613-1621
pubmed: 28180946
J Clin Pharmacol. 2021 Jun;61 Suppl 1:S175-S187
pubmed: 34185913
Clin Pharmacol Ther. 1996 Mar;59(3):332-40
pubmed: 8653996
Acta Anaesthesiol Scand. 2008 Nov;52(10):1319-26
pubmed: 19025521
Eur J Clin Pharmacol. 2017 Sep;73(9):1181-1185
pubmed: 28624887
Nat Rev Dis Primers. 2019 Aug 22;5(1):58
pubmed: 31439850
Pediatr Blood Cancer. 2019 Oct;66(10):e27915
pubmed: 31309711
J Oncol Pharm Pract. 2009 Sep;15(3):175-82
pubmed: 19282418
BMC Cancer. 2007 Apr 19;7:68
pubmed: 17445267
Bone Marrow Transplant. 2018 Apr;53(4):449-456
pubmed: 29330398
Mycoses. 2020 Oct;63(10):1101-1106
pubmed: 32738006
Br J Haematol. 2018 Oct;183(1):87-95
pubmed: 30074239
Pediatr Blood Cancer. 2004 Dec;43(7):749-57
pubmed: 15390289
J Clin Oncol. 2020 Sep 20;38(27):3205-3216
pubmed: 32459599
J Fungi (Basel). 2019 Oct 11;5(4):
pubmed: 31614505
BMC Cancer. 2005 Apr 04;5:33
pubmed: 15807901
Blood. 2010 Apr 22;115(16):3206-14
pubmed: 20154213
Arch Dis Child. 2007 Oct;92(10):890-7
pubmed: 17566053
Acta Paediatr. 2019 Jun;108(6):1128-1132
pubmed: 30456871
J Pharm Pharm Sci. 2022;25:237-243
pubmed: 35790147
Mycoses. 2003 Dec;46(11-12):441-6
pubmed: 14641615
Pediatrics. 2015 Jan;135(1):e99-108
pubmed: 25511114
Eur J Clin Microbiol Infect Dis. 2011 Apr;30(4):595-6
pubmed: 21120565
Front Pharmacol. 2022 Apr 28;13:891336
pubmed: 35571077
Mycoses. 2012 Jul;55(4):290-7
pubmed: 22126626
Pediatr Crit Care Med. 2016 May;17(5):e218-28
pubmed: 26959349
JAMA. 2021 Mar 2;325(9):833-842
pubmed: 33651090
J Am Med Inform Assoc. 2019 Oct 1;26(10):1141-1149
pubmed: 31206159
Expert Opin Drug Saf. 2017 Feb;16(2):149-165
pubmed: 27927037
Clin Pharmacol Ther. 2019 Jun;105(6):1345-1361
pubmed: 30916389
Blood. 2020 Oct 15;136(16):1803-1812
pubmed: 32589723
Cancer Chemother Pharmacol. 2013 Jun;71(6):1619-27
pubmed: 23589317
Eur J Clin Pharmacol. 2016 Nov;72(11):1363-1371
pubmed: 27510521
Eur J Haematol. 2018 Mar;100(3):315-322
pubmed: 29240266
Haematologica. 2019 Sep;104(9):1812-1821
pubmed: 30705097
J Res Pharm Pract. 2016 Oct-Dec;5(4):257-263
pubmed: 27843962
Pediatr Blood Cancer. 2009 Jul;53(1):13-6
pubmed: 19260104
Clin Infect Dis. 2019 May 2;68(Suppl 4):S260-S274
pubmed: 31222253
Paediatr Drugs. 2020 Aug;22(4):425-432
pubmed: 32557243
Leuk Res. 2014 Jun;38(6):699-705
pubmed: 24720908
Pediatr Blood Cancer. 2008 Feb;50(2):325-30
pubmed: 17514732
J Pak Med Assoc. 2020 Apr;70(4):591-596
pubmed: 32296200
Lancet Oncol. 2021 Jun;22(6):e254-e269
pubmed: 33811813
Int J Clin Pharm. 2014 Dec;36(6):1160-9
pubmed: 25204258
Int J Mol Sci. 2021 Apr 26;22(9):
pubmed: 33925883
Lancet. 2013 Jun 1;381(9881):1943-55
pubmed: 23523389
Expert Opin Drug Metab Toxicol. 2018 Apr;14(4):447-460
pubmed: 29620484
Eur J Cancer. 2004 Jun;40(9):1351-60
pubmed: 15177495
Br J Haematol. 2019 Jul;186(2):327-329
pubmed: 30768682
Pediatr Infect Dis J. 2011 Jun;30(6):508-9
pubmed: 21587028
J Antimicrob Chemother. 2011 Aug;66(8):1853-6
pubmed: 21652620
Biol Blood Marrow Transplant. 2006 Feb;12(2):235-40
pubmed: 16443521
Postgrad Med J. 2021 Jul;97(1149):452-458
pubmed: 33122341
J Antimicrob Chemother. 2020 Jan 1;75(1):221-228
pubmed: 31580432
Br J Cancer. 2000 Dec;83(12):1617-22
pubmed: 11104555
Transl Pediatr. 2023 Mar 31;12(3):487-502
pubmed: 37035397
J Cheminform. 2022 Apr 15;14(1):23
pubmed: 35428354
Pharmacoepidemiol Drug Saf. 2011 Dec;20(12):1295-302
pubmed: 21793098
J Anal Toxicol. 2015 Jun;39(5):374-86
pubmed: 25868557
Intern Med J. 2021 Nov;51 Suppl 7:37-66
pubmed: 34937141